This section doesn’t currently include any content. Add content to this section using the sidebar.

Image caption appears here

COVID-19 Update

Dear BioNox customer. We know many of you may be struggling with finding things you commonly purchase and need during this time of crisis. For those who use our M3 Miracle Molecule Max product, we want you to know that we have plenty of inventory on our site

For those who are wondering about the Covid19 virus and its risks, we have some possibly disturbing information that we feel everyone should consider. 

For those taking ACE inhibitors such as the following:

  • benazepril (LotensinLotensin Hct),
  • captopril (Capoten),
  • enalapril (Vasotec),
  • fosinopril (Monopril),
  • lisinopril (PrinivilZestril),
  • moexipril (Univasc)
  • perindopril (Aceon),
  • quinapril (Accupril),

or for those taking ARBs such as:

  •  azilsartan (Edarbi)
  • candesartan (Atacand),
  • eprosartan (Teveten),
  • irbesartan (Avapro),
  • telmisartan (Micardis),
  • valsartan (Diovan),
  • losartan (Cozaar), and.
  • olmesartan (Benicar).

Some information appearing online recently about these medications seems to point to these medications possibly being related to worsening symptoms from the infection. As is the case almost always, the pharmaceutical industry and some doctors are denying this, and other doctors are confirming it. Some reports out of Wuhan China report that 40% of the dead had a history of cardiovascular issues. [1]

If your taking M3 Miracle Molecule Max, you do not have to worry about these additional risk factors. M3 is a natural blood pressure support product and does not work the same way as the medications above.

We are NOT suggesting you make any changes to your current medications without first talking with your medical professional. We just want you to understand the risks that have been associated with these medications.  

If you would like more information about the possible risks of the medications your taking and the Covid19 virus, you may want to check out the following video.